Health News Releases

  • Today May 19
February 16, 2017 11:28
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
Boehringer Ingelheim today announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD) in order to develop novel treatme
February 15, 2017 13:50
25 Hospitals in Mexico Make a Commitment to Eliminate Preventable Death
Dr. Javier Dávila Torres, along with 11 officials from Mexico announced at the Patient Safety Movement Foundation’s (PSMF) World Patient Safety, Science & Technology Summit that 25 hospitals signed a
February 14, 2017 11:30
WIN 2017 Symposium, Expediting Global Innovation in Precision Cancer Medicine
WIN 2017 Symposium will be held in Paris, France from June 26-27, 2017. The CME accredited WIN2017 is an exceptional scientific event dedicated to “Expediting Global Innovation in Precision Cancer Med
February 13, 2017 17:30
Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
Ferring Pharmaceuticals and Foresee Pharmaceuticals Co., Ltd. (6576.TWO), announced today that the companies have entered into an exclusive worldwide development and option agreement to leverage Fores
February 13, 2017 10:25
Replicor Discloses Updated REP 401 Clinical Data at APASL 2017
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced that an updated interim analysis from its latest REP 401 clinical tri
February 13, 2017 09:50
Renowned South Korean Pop Singer Hwang Chi-yeul Performs in Taiwan
Renowned South Korean pop singer-songwriter Hwang Chi-yeul will soon perform a live concert in Taiwan held by biotech company, Bioworld Nature, as part of the company’s “Thank-you event,” the event or
February 10, 2017 10:40
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung
Boehringer Ingelheim today announced the initiation of a Phase II trial of afatinib* (Giotrif®) in combination with pembrolizumab (Keytruda®) for patients with locally advanced or metastatic squamous
February 06, 2017 13:55
Patient Safety Movement Announces Innovation Award Winners at 5th Annual Summit
At the 5th Annual World Patient Safety, Science & Technology Summit, the winners of this year’s Innovation Awards were announced. The annual summit convened hundreds of medical professionals, hospital
February 06, 2017 10:25
Patient Safety Movement Announces 69,519 Lives Saved
The Patient Safety Movement Foundation (PSMF) announced today, at the 5th Annual Patient Safety, Science & Technology Summit, that 69,519 lives were saved in 2016, thanks to the efforts of more than 3
February 03, 2017 11:25
CellProthera Raises 8.3 Million Euros
CellProthera, a biotech company which offers the most advanced cell therapy for regeneration of the damaged heart muscle after myocardial infarction, announces it has raised €8,300,000 from private in
February 03, 2017 10:10
Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide) Indication as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma (MM) after Autologous Stem Cell Transplantation
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (C
February 02, 2017 14:00
Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring and Connectivity Platform
Masimo (NASDAQ: MASI) announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital
February 02, 2017 10:30
Takeda Reports Q3 FY2016 Results and Improves Year-End Outlook
Takeda Pharmaceutical Company Limited (TOKYO: 4502): Strong Q3 year-to-date (YTD) results propelled by Growth Drivers · Underlying Revenue grew +7.4%, with Takeda's Growth Drivers (GI, Oncology,
DMO booth in MIDO 2017 (25th~27th. February, Booth No. Hall3, F19)
February 01, 2017 16:08
Daemyung Optical to exhibit at global optic fair in SIOF and MIDO 2017
Daemyung Optical Co., Ltd. announced that it will be exhibiting at the International Eyewear Show MIDO 2017, which will be held in Fieramilano Rho-Pero Pavilions, Milan, Italy, from Feb. 25th to 27th,
February 01, 2017 13:30
Chiltern Expands Footprint in Bangalore, India, to Meet Global Data Demand
Chiltern, a leading global contract research organization, has announced the opening of its new process and technology center in Bangalore, India. The new office is a direct result of the company’s co
February 01, 2017 10:55
Exelixis and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan
Exelixis, Inc. (NASDAQ:EXEL) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced an exclusive licensing agreement for the commercialization and further clinical development in Japan o
January 31, 2017 14:00
Vice President Joe Biden to Deliver Keynote Remarks at 5th Annual World Patient Safety, Science & Technology Summit
The Patient Safety Movement Foundation (PSMF) announced today that former Vice President Joe Biden will deliver the keynote address on the first day of the 5th Annual World Patient Safety, Science & T
January 31, 2017 11:40
FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery
W. L. Gore & Associates (Gore) has announced that the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received U.S. Food & Drug Administration (FDA) approval for treatment o
January 31, 2017 09:15
Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic
Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced today that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris’ proprieta
January 30, 2017 09:55
Jardiance® (empagliflozin) becomes first type 2 diabetes medicine in the EU to include cardiovascular death reduction data in label
The European Commission has approved an update to the Jardiance® (empagliflozin) label to include a change to the indication statement. Jardiance® is now indicated for the treatment of adults with ins
January 23, 2017 10:40
Takeda Recognized as One of the Global 100 Most Sustainable Corporations for Second Consecutive Year
Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index. Takeda achieved this d
January 20, 2017 15:55
Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced the commencement of the cash tender offer by its wholly-owned indirect subsidiary, Kiku Merger Co., Inc., for all outstand
January 20, 2017 15:25
For the 1st Time, the Annual World Patient Safety, Science & Technology Summit Will Be Streamed Live in HD Outside of the United States
The Patient Safety Movement Foundation (PSMF) announced today that it will offer livestreaming of the sold-out 5th annual World Patient Safety, Science & Technology Summit to viewers outside of the Un
January 20, 2017 15:00
InFo 124M - Swiss Made EDOF IOL for Cataract Surgery
The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com) continues to expand its portfolio of intraocular lenses (IOLs) announcing the launch of a new product range based on the first InFo ser
January 19, 2017 11:40
Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review
Boehringer Ingelheim announced today that BI 695501, its adalimumab biosimilar candidate to Humira®*, has been accepted for regulatory review by the European Medicines Agency (EMA) and the U.S Food an
25 per page50 per page75 per page100 per page